Company: IRadimed Corporation
Ticker: Nasdaq: IRMD
Sector: Healthcare
Investor Contact: Joe Dorame

IRadimed Corporation News

News

IRADIMED CORPORATION Announces Second Quarter 2016 Financial Results

Revenue grows 29.7% compared to the same quarter last yearReports second quarter 2016 GAAP diluted EPS of $0.19 and non-GAAP diluted EPS of $0.24Increases full year 2016 non-GAAP earnings guidanceSubmits patient vital signs monitor 510(k) application to FDA for review...

IRADIMED CORPORATION Provides Regulatory Update

Provides regulatory update on the status of its MRI compatible IV infusion pump WINTER SPRINGS, Fla., June 09, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) CURRENT NEWSIRADIMED CORPORATION has received the FDA's written response to our appeal of their determination that...

IRADIMED CORPORATION Announces First Quarter 2016 Financial Results

Revenue grows 28.2% compared to the same quarter last yearReports first quarter 2016 non-GAAP diluted EPS of $0.21Increases full year 2016 non-GAAP earnings guidanceAnnounces second quarter financial guidance WINTER SPRINGS, Fla., April 29, 2016 -- IRADIMED...

Skip to content